A Clinical Pharmacology and Exploratory Study of Bortezomib in Combination With Melphalan and Prednisolone in Previously Untreated Multiple Myeloma Patients
This study has been completed.
Sponsor:
Janssen Pharmaceutical K.K.
Information provided by (Responsible Party):
Janssen Pharmaceutical K.K.
ClinicalTrials.gov Identifier:
NCT00985959
First received: September 18, 2009
Last updated: January 31, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2010 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |